JP2007515157A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007515157A5 JP2007515157A5 JP2006538952A JP2006538952A JP2007515157A5 JP 2007515157 A5 JP2007515157 A5 JP 2007515157A5 JP 2006538952 A JP2006538952 A JP 2006538952A JP 2006538952 A JP2006538952 A JP 2006538952A JP 2007515157 A5 JP2007515157 A5 JP 2007515157A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- acid sequence
- amino acid
- diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0326393.6 | 2003-11-12 | ||
| GBGB0326393.6A GB0326393D0 (en) | 2003-11-12 | 2003-11-12 | Cytokine antagonist molecules |
| PCT/GB2004/004772 WO2005046714A2 (en) | 2003-11-12 | 2004-11-12 | Cytokine antagonist molecules |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007515157A JP2007515157A (ja) | 2007-06-14 |
| JP2007515157A5 true JP2007515157A5 (enExample) | 2007-12-06 |
| JP5047623B2 JP5047623B2 (ja) | 2012-10-10 |
Family
ID=29726416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006538952A Expired - Fee Related JP5047623B2 (ja) | 2003-11-12 | 2004-11-12 | サイトカインアンタゴニスト分子 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7803383B2 (enExample) |
| EP (1) | EP1682164A2 (enExample) |
| JP (1) | JP5047623B2 (enExample) |
| KR (1) | KR20070029636A (enExample) |
| CN (1) | CN1901932A (enExample) |
| AU (1) | AU2004289105B2 (enExample) |
| BR (1) | BRPI0416507A (enExample) |
| CA (1) | CA2544308A1 (enExample) |
| EA (1) | EA010420B1 (enExample) |
| GB (1) | GB0326393D0 (enExample) |
| IL (1) | IL175569A (enExample) |
| NO (1) | NO20062657L (enExample) |
| WO (1) | WO2005046714A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201315486D0 (en) * | 2013-08-30 | 2013-10-16 | Ucb Pharma Sa | Antibodies |
| CN104293815A (zh) * | 2014-09-18 | 2015-01-21 | 扬州大学 | 一种纳米基因疫苗及其制备方法和应用 |
| CA2964361A1 (en) | 2014-10-14 | 2016-04-21 | The Usa, As Represented By The Secretary, Dept. Of Health & Human Services | Peptide-based methods for treating pancreatic cancer |
| EP3112375A1 (en) * | 2015-07-03 | 2017-01-04 | Ludwig-Maximilians-Universität München | Antigenic peptides for the diagnosis, therapy monitoring and/or treatment of psoriasis vulgaris |
| US10413584B1 (en) | 2018-08-29 | 2019-09-17 | Riptide Bioscience, Inc. | Peptides having immunomodulatory properties |
| US10548944B1 (en) | 2018-10-19 | 2020-02-04 | Riptide Bioscience, Inc. | Antimicrobial peptides and methods of using the same |
| CA3134420A1 (en) | 2019-04-12 | 2020-10-15 | Riptide Bioscience, Inc. | Methods for modulating macrophage activity |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6420526B1 (en) * | 1997-03-07 | 2002-07-16 | Human Genome Sciences, Inc. | 186 human secreted proteins |
| US6458777B1 (en) * | 1998-03-13 | 2002-10-01 | Mucosal Therapeutics Llc | Methods and compositions for treating and preventing mucositis |
| US6783961B1 (en) * | 1999-02-26 | 2004-08-31 | Genset S.A. | Expressed sequence tags and encoded human proteins |
| US6867299B2 (en) * | 2000-02-24 | 2005-03-15 | Hoffmann-La Roche Inc. | Oxamide IMPDH inhibitors |
| WO2002040671A2 (en) * | 2000-11-16 | 2002-05-23 | Incyte Genomics, Inc. | Immunoglobulin superfamily proteins |
| US20040043424A1 (en) * | 2001-11-15 | 2004-03-04 | Baughn Mariah R | Immunoglobulin superfamily proteins |
| IL148736A0 (en) * | 2002-03-18 | 2002-09-12 | Pharmos Corp | Dexanabinol and dexanabinol analogs which regulate inflammation related genes |
| GB0209884D0 (en) * | 2002-04-30 | 2002-06-05 | Ares Trading Sa | Proteins |
| EP1576116A4 (en) | 2002-07-12 | 2008-01-09 | Nuvelo Inc | METHOD AND MATERIALS RELATING TO NEW POLYPEPTIDES AND POLYNUCLEOTIDES |
| AU2003303305A1 (en) | 2002-10-02 | 2004-09-30 | Nuvelo,Inc. | Novel nucleic acids and polypeptides |
-
2003
- 2003-11-12 GB GBGB0326393.6A patent/GB0326393D0/en not_active Ceased
-
2004
- 2004-11-12 JP JP2006538952A patent/JP5047623B2/ja not_active Expired - Fee Related
- 2004-11-12 EA EA200600956A patent/EA010420B1/ru not_active IP Right Cessation
- 2004-11-12 KR KR1020067010318A patent/KR20070029636A/ko not_active Withdrawn
- 2004-11-12 US US10/579,113 patent/US7803383B2/en not_active Expired - Fee Related
- 2004-11-12 CN CNA2004800397773A patent/CN1901932A/zh active Pending
- 2004-11-12 AU AU2004289105A patent/AU2004289105B2/en not_active Ceased
- 2004-11-12 CA CA002544308A patent/CA2544308A1/en not_active Abandoned
- 2004-11-12 BR BRPI0416507-1A patent/BRPI0416507A/pt not_active IP Right Cessation
- 2004-11-12 WO PCT/GB2004/004772 patent/WO2005046714A2/en not_active Ceased
- 2004-11-12 EP EP04798495A patent/EP1682164A2/en not_active Withdrawn
-
2006
- 2006-05-11 IL IL175569A patent/IL175569A/en not_active IP Right Cessation
- 2006-06-09 NO NO20062657A patent/NO20062657L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5022216B2 (ja) | 自己炎症性疾患を処置するためのｉｌ−１アンタゴニストを使用する方法 | |
| JP5805634B2 (ja) | 成長ホルモンポリペプチド並びにその作成及び使用方法 | |
| JP2010513506A5 (enExample) | ||
| EP2343081A1 (en) | Interferon analogs | |
| KR20090039787A (ko) | 인간 ｇｌｐ-1 모방체, 조성물, 방법 및 용도 | |
| JP2022002528A (ja) | 組織修復のための二重特異性治療用タンパク質 | |
| KR20070004078A (ko) | 인간 ｇｌｐ-1 모방체, 조성물, 방법 및 용도 | |
| JP2011530599A5 (enExample) | ||
| CN106573072A (zh) | 降低血清胆固醇的方法 | |
| EP2663578A2 (en) | Il-27 antagonists for treating inflammatory diseases | |
| JP2006502702A5 (enExample) | ||
| CN104710533A (zh) | sDR5-Fc融合蛋白及其用途 | |
| JP2007515157A5 (enExample) | ||
| CA2952902C (en) | Anti-il4-il 13 bispecific antibodies | |
| JP2022531389A (ja) | 免疫調節用組成物および方法 | |
| EP3420087B1 (en) | Peptide-based methods for treating neurological injury | |
| US7335350B2 (en) | Chemokines mutants having improved oral bioavailability | |
| CN114853911A (zh) | 三叶因子2/干扰素α2融合蛋白及其防治病毒感染性疾病的应用 | |
| JP4520951B2 (ja) | インスリン分泌誘導剤及びインスリン分泌誘導組成物 | |
| KR20240110819A (ko) | Dsg2 조성물 및 방법 | |
| KR20080005378A (ko) | 인간 ｇｌｐ-1 모방체, 조성물, 방법 및 용도 | |
| JP2017509602A5 (enExample) | ||
| WO2023225802A1 (zh) | 三叶因子2/干扰素α2融合蛋白及其防治病毒感染性疾病的应用 | |
| WO2009101856A1 (ja) | 関節リウマチ治療剤 | |
| JPWO2020109978A5 (enExample) |